Andrew Turitz - Sep 4, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
EVP, CORPORATE DEVELOPMENT
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Sep 4, 2024
Transactions value $
-$150,812
Form type
4
Date filed
9/5/2024, 04:05 PM
Previous filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Sale -$151K -20.8K -50% $7.26 20.8K Sep 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Andrew Turitz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.